SCHEMBL7185686

SCHEMBL7185686

COc1cccc(OC)c1/C=C/C(=O)c1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.80
MAOA P21397 2/20 0.56
CYP1A2 P05177 3/20 0.53
CYP2D6 P10635 2/20 0.53
CYP1A1 P04798 1/20 0.53
NPC1 O15118 2/20 0.51
LMNA P02545 2/20 0.51
MAPT P10636 2/20 0.51
BCHE P06276 1/20 0.51
RAB9A P51151 1/20 0.51
MAOB P27338 3/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
ALOX5 P09917 1/20 0.50
HPGD P15428 1/20 0.50
RECQL P46063 1/20 0.50
GPR55 Q9Y2T6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185692 1.00 ABCG2 (0.80) ABCG2MAOACYP1A2CYP2D6CYP1A1
SCHEMBL7184854 0.86 ABCG2 (0.58) ABCG2MAOACYP1A2CYP2D6NPC1
SCHEMBL7184850 0.86 ABCG2 (0.58) ABCG2MAOACYP1A2CYP2D6NPC1
SCHEMBL7180373 0.85 ABCG2 (0.57) ABCG2MAOANPC1LMNAMAPT
SCHEMBL7191499 0.85 ABCG2 (0.57) ABCG2MAOACYP1A2CYP2D6CYP1A1
SCHEMBL7191503 0.85 ABCG2 (0.57) ABCG2MAOACYP1A2CYP2D6CYP1A1
SCHEMBL7180369 0.85 ABCG2 (0.57) ABCG2MAOANPC1LMNAMAPT
SCHEMBL9207333 0.84 MAPT (0.74) ABCG2CYP1A2CYP2D6CYP1A1NPC1
SCHEMBL9207320 0.84 MAPT (0.74) ABCG2CYP1A2CYP2D6CYP1A1NPC1
SCHEMBL7185747 0.84 ABCG2 (0.88) ABCG2MAOACYP1A2CYP2D6CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed